Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 161 Neoplasm Metastasis 27 Neoplasms 25 Breast Neoplasms, Male 15 Brain Neoplasms 14 Head and Neck Neoplasms 8 Urinary Bladder Neoplasms 7 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Inflammatory Breast Neoplasms 5 Glioblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Salivary Gland Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Gliosarcoma 3 Glioma 3 Gallbladder Neoplasms 3 Ependymoma 3 Carcinoma, Squamous Cell 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Osteitis Deformans 2

Interventions

Surveys and Questionnaires 2 bemarituzumab 1 Radiotherapy 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Lapatinib 1 Irinotecan 1 Fluorouracil 1 Exercise 1 Diet Therapy 1 Carboplatin 1 Capecitabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × GastroEsophageal Cancer × Lapatinib × Clear all

NCT01145404 2014-07-02

GastroLap

National Center for Tumor Diseases, Heidelberg

Phase 2 Terminated

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡